Using fecal microbiota to treat gut acute graft-versus-host disease

Department of Hematology of First Affiliated Hospital of Soochow University

Observational The First Affiliated Hospital of Soochow University · NCT03148743

This study is testing whether fecal microbiota transplantation can help improve gut symptoms in patients with acute graft-versus-host disease after stem cell transplantation.

Quick facts

Study typeObservational
Enrollment50 (estimated)
Ages10 Years to 60 Years
SexAll
SponsorThe First Affiliated Hospital of Soochow University Academic / other
Locations1 site (Suzhou, Jiangsu)
Trial IDNCT03148743 on ClinicalTrials.gov

What this trial studies

This observational study evaluates the safety and efficacy of fecal microbiota transplantation (FMT) in patients suffering from gut acute graft-versus-host disease (aGVHD) following stem cell transplantation. Patients diagnosed with gut GVHD will be recruited to assess how FMT can potentially improve their condition. The study aims to gather data on the outcomes of FMT in this specific patient population, contributing to the understanding of treatment options for gut GVHD.

Who should consider this trial

Good fit: Ideal candidates for this study are patients diagnosed with gut acute graft-versus-host disease.

Not a fit: Patients over the age of 60 or under the age of 10 will not benefit from this study.

Why it matters

Potential benefit: If successful, this approach could provide a new therapeutic option for patients suffering from gut aGVHD.

How similar studies have performed: While this approach is being explored, the specific application of FMT for gut aGVHD is still relatively novel and has not been extensively tested in prior studies.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* gut GVHD

Exclusion Criteria:

* Age\>60; or Age\<10

Where this trial is running

Suzhou, Jiangsu

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Acute-graft-versus-host Disease
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.